Article
Covariate-adjusted non-parametric survival curve estimation.
Eli Lilly and Company, US Commercial Information Sciences, IN 46285, USA.
Statistics in Medicine (impact factor:
1.88).
02/2011;
30(11):1243-53.
DOI:10.1002/sim.4216
pp.1243-53
Source: PubMed
-
Citations (0)
-
Cited In (0)
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
covariate adjustment
Cox proportional hazards model
estimate covariate-adjusted survival curves
estimate survival rates
increase precision
Kaplan-Meier survival curve estimation
non-parametric covariate-adjusted method
oncology clinical trial example
proportional hazards assumption
survival distributions
survival rates
time intervals
time point
used non-parametric method
used semi-parametric method